Mobile Menu - OpenMobile Menu - Closed

Pallone Highlights RWJBarnabas Health Investments in Monmouth Medical Center

December 6, 2018
Press Release

Washington, D.C.-  Today Congressman Frank Pallone, Jr. (NJ-06) held a roundtable at Monmouth Medical Center (MMC) with administrators and health professionals to discuss investments by the RWJBarnabas Health System in the MMC campus and the center’s growing role as a healthcare leader in New Jersey. Investments in MMC’s Comprehensive Breast Center, for example, have led to national recognition for its use of robotics for mastectomies.

“Monmouth Medical Center is one of the leading health providers in New Jersey and I am pleased to see additional investments being made to grow its impact,” said Pallone. “The work being done in areas such as robotic surgery is just one example of why MMC is receiving national recognition. As the Chairman of the House Energy Commerce Committee, I will continue to promote and support MMC’s mission in any way I can.”

MMC has been recognized nationally for patient safety and quality, and is one of eight New Jersey hospitals to receive a four-star rating from The Centers for Medicare and Medicaid Services, the highest hospital rating in the state. It is also the region’s only hospital to achieve an A grade from The Leapfrog Group in five key safety scores. It has also been recognized for its Jacqueline M. Wilentz Comprehensive Breast Center.
Most recently, MMC has expanded the use of these robotic surgery tools to diagnose and combat breast cancer. Traditional techniques may require a heavily invasive and potentially life-altering mastectomy, which may require cosmetic surgery. MMC’s robotics technology allows surgeons to make small incisions on the side of the breast and replace any tissue they remove with an implant during the same procedure. The robotics technique leaves no scarring, and patients typically encounter less pain, shorter hospital stays, and a quicker return to normal activities.

Pallone is slated to become Chairman of the House Energy and Commerce Committee in the new Congress in January. The committee’s jurisdiction includes healthcare and health research.